Reducing Cost and Complexity of Fecal Microbiota Transplantation Using Universal Donors for Recurrent Clostridium difficile Infection.

Kyeong Ok KimMargot A SchwartzOtto S T LinMichael V ChioreanMichael Gluck

Published in: Advances in therapy (2019)

Fecal microbiota transplantation using universal donors versus patient-directed donors for recurrent C. difficile showed comparable efficacy and short-term complications. The use of universal donors resulted in significant cost savings and scheduling efficiency.

Keyphrases

kidney transplantation
cell therapy
mesenchymal stem cells
bone marrow